CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,141,003 | -22.7% | 87,782 | 0.0% | 0.02% | -34.5% |
| Q4 2022 | $2,768,644 | +11.6% | 87,782 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $2,481,000 | -32.5% | 87,782 | -16.4% | 0.03% | -29.3% |
| Q1 2022 | $3,676,000 | -70.7% | 105,000 | -75.3% | 0.04% | -73.5% |
| Q3 2021 | $12,531,000 | -40.7% | 424,767 | -48.5% | 0.16% | -36.5% |
| Q2 2021 | $21,121,000 | +51.9% | 824,389 | -18.6% | 0.24% | +36.3% |
| Q1 2021 | $13,901,000 | -37.5% | 1,012,480 | -24.5% | 0.18% | -43.0% |
| Q4 2020 | $22,242,000 | – | 1,341,485 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 65,679,781 | $2,685,646,245 | 57.02% |
| Twin Securities, Inc. | 416,657 | $17,037,105 | 13.40% |
| Sand Grove Capital Management LLP | 919,023 | $37,578,850 | 10.99% |
| Perceptive Advisors | 10,794,876 | $441,402,480 | 10.63% |
| P SCHOENFELD ASSET MANAGEMENT LP | 796,440 | $32,566,432 | 7.87% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,353,694 | $96,242,547 | 4.60% |
| Avoro Capital Advisors LLC | 7,539,547 | $308,292,077 | 4.11% |
| Melqart Asset Management (UK) Ltd | 1,099,229 | $44,947,474 | 3.72% |
| Paradigm Biocapital Advisors LP | 2,330,508 | $95,294,472 | 3.65% |
| WATER ISLAND CAPITAL LLC | 766,933 | $31,360 | 3.33% |